RSV Prevention in All Infants: Which Is the Most Preferable Strategy?

Esposito S, Abu Raya B, Baraldi E, Flanagan K, Martinon Torres F, Tsolia M, Zielen S

Open source

DOI
10.3389/fimmu.2022.880368
Published
2022
Container
Frontiers in immunology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2022.880368,
  title = {RSV Prevention in All Infants: Which Is the Most Preferable Strategy?},
  author = {Esposito S and Abu Raya B and Baraldi E and Flanagan K and Martinon Torres F and Tsolia M and Zielen S},
  year = {2022},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2022.880368},
  url = {https://doi.org/10.3389/fimmu.2022.880368}
}

RIS

TY  - JOUR
TI  - RSV Prevention in All Infants: Which Is the Most Preferable Strategy?
AU  - Esposito S
AU  - Abu Raya B
AU  - Baraldi E
AU  - Flanagan K
AU  - Martinon Torres F
AU  - Tsolia M
AU  - Zielen S
PY  - 2022
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2022.880368
UR  - https://doi.org/10.3389/fimmu.2022.880368
ER  - 

APA

S, E., B, A. R., E, B., K, F., F, M. T., M, T., & S, Z. (2022). RSV Prevention in All Infants: Which Is the Most Preferable Strategy?. Frontiers in immunology. https://doi.org/10.3389/fimmu.2022.880368

Source records